We determined that IKAROS regulates CD19 expression in B-ALL, large B cell lymphoma (LBCL), and chronic lymphoblastic lymphoma (CLL) models. The gene discussed is CD19; the disease is precursor B-cell acute lymphoblastic leukemia.